Patent(s) and the Corresponding Patented Drug(s) |
Top |
World Intellectual Property Organization (WIPO) |
Patent ID |
WO2015124934 |
Title |
Substituted Cyclopentanes, Tetrahydrofuranes and Pyrrolidines As orexin Receptor Antagonists. |
Abstract |
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, Formula (I) wherein L,X, Ra, Rb, R 1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. |
Applicant(s) |
Takeda Cambridge Limited Takeda Pharmaceutical Company Limited |
Representative Drug(s) |
D0CG0D |
Drug Info
|
IC50 > 10000 nM |
Click to Show More |
[1] |
2
|
D0EG3N
|
Drug Info
|
IC50 > 10000 nM
|
[1] |
Patent ID |
WO2015124932 |
Title |
1,2-Substituted Cyclopentanes As orexin Receptor Antagonists. |
Abstract |
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, (I) wherein L,X, Ra, Rb, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. |
Applicant(s) |
Takeda Cambridge Limited Takeda Pharmaceutical Company Limited |
Representative Drug(s) |
D09XLY |
Drug Info
|
IC50 = 5569 nM |
Click to Show More |
[1] |
2
|
D06OTA
|
Drug Info
|
IC50 > 10000 nM
|
[1] |
3
|
D0S4UG
|
Drug Info
|
IC50 > 10000 nM
|
[1] |
4
|
D0U9WX
|
Drug Info
|
IC50 > 10000 nM
|
[1] |